Perioperative chemotherapy in patients with oral cancer

The American Journal of Surgery

Volumn 168, Issue 3, 1994, Pages 262-267

  Rao, Raja S ^a   Parikh, Deepak M ^a   Parikh, Hemen K ^a   Bhansali, Mehul B ^a   Deshmane, Vinay H ^a   Fakih, Abdul R ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MORBIDITY; MOUTH CANCER; MUCOSA INFLAMMATION; NECK DISSECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES;

EID: 0028063276     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(05)80199-0     Document Type: Article

References (20)

1. Moderate dose methotrexate in head and neck cancer
2. Adjuvant chemotherapy of head and neck cancer, the past, the present and the future
3. Chemotherapy for head and neck cancer. Progress and controversy in the management of patients with M0 disease
4. Controversies in the multimodality management of head and neck cancer
5. Adjuvant chemotherapy for head and neck cancer
6. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate
7. Theoretical consideration regarding the early use of adjuvant chemotherapy
8. Factors affecting the development of permanent drug resistance and its impact upon neoadjuvant chemotherapy
9. Perioperative chemotherapy in oral cancer
10. Laryngeal preservation with induction chemotherapy (CT) and Radiotherapy (XRT) in the treatment of advanced laryngeal cancer: interim survival data of VACSP 268. V.A. Laryngeal Cancer Study Group
11. Neoadjuvant treatment of tongue and floor of the mouth cancers
12. Adjuvant chemotherapy after surgery and radiotherapy for stage III and IV head and neck cancer
13. Adjuvant chemotherapy with vincristine, cyclophosphamide and doxorubicin after radiotherapy in locoregional nasopharyngeal cancer. Results of a 4 year multicentric randomised study
14. Post surgical adjuvant chemotherapy in extra capsular spread invaded lymph nodes of epidermoid carcinoma of head and neck. A randomised multicentric trial
15. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous cell carcinoma of the head and neck
16. Adjuvant chemotherapy for advanced head and neck squamous carcinoma
17. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer, a subset analysis of the head and neck contracts programme
18. Adjuvant methotrexate, 5 fluorouracil for extra-capsular squamous cell carcinoma in cervical metastases
19. Surgical adjuvant chemotherapy—results with one course with cyclophosphamide after mastectomy for breast cancer
20. A randomised comparison of high dose infusion methotrexate versus standard dose weekly therapy in head and neck squamous cancer